News

Scientists from the Icahn School of Medicine at Mount Sinai have developed a new approach to build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping.

Dr. Hoffmann will support the further growth of the Company’s Discovery business.

Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.

Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.

Creating bacterial “fight clubs” is an effective way to find new drugs from natural sources.

IND grants TxCell option of extending current phase 2b study from EU to US.

Amine Tahiri has joined the Development Services Sales team with effect from 1 July 2015.

Rudi Vollmer becomes new Technical Managing Director of Greiner Bio-One GmbH, responsible for production and technology.

Acquisition adds novel angiotensin II Type 2 receptor antagonist for the treatment of neuropathic pain to Novartis' industry-leading development pipeline.